|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.050 USD | +1.20% |
|
+9.78% | -23.25% |
| 06-29 | Immuneering Corporation(NasdaqGM:IMRX) added to Russell 2000 Index | CI |
| 06-29 | Immuneering Corporation(NasdaqGM:IMRX) added to Russell 2000 Value Benchmark | CI |
| Market Cap | 327M 287M 264M 246M 464M 31.06B 473M 3.18B 1.23B 15.25B 1.23B 1.2B 53.06B | P/E 2026 * |
-4.44x | P/E 2027 * | -3.77x |
|---|---|---|---|---|---|
| Enterprise Value | 327M 287M 264M 246M 464M 31.06B 473M 3.18B 1.23B 15.25B 1.23B 1.2B 53.06B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 20.4x |
| Free-Float |
86.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Immuneering Corporation
| 1 day | +1.20% | ||
| 1 week | +9.78% | ||
| Current month | +1.20% | ||
| 1 month | +12.35% | ||
| 3 months | -5.25% | ||
| 6 months | -23.25% | ||
| Current year | -23.25% |
| 1 week | 4.48 |  | 5.18 |
| 1 month | 3.86 | | 5.18 |
| Current year | 3.86 | | 8.48 |
| 1 year | 2.9 | | 10.08 |
| 3 years | 1 | | 11.06 |
| 5 years | 1 | | 33.99 |
| 10 years | 1 | | 33.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Benjamin Zeskind
CEO | Chief Executive Officer | 44 | 2008-01-31 |
Mallory Morales
DFI | Director of Finance/CFO | 42 | 2022-08-09 |
Scott Nguyen
CTO | Chief Tech/Sci/R&D Officer | - | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Carpenter
CHM | Chairman | 81 | 2007-12-31 |
Benjamin Zeskind
BRD | Director/Board Member | 44 | 2008-01-31 |
Laurie Keating
BRD | Director/Board Member | 72 | 2021-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Buy | Founder | 2,400 | 0.0037% | ||
| 06-14 | Buy | Chief Technology Officer | 6,035 | 0.0093% | ||
| 06-10 | Free | Director | 33,350 | 0.0515% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.20% | +9.78% | +46.80% | -50.20% | 327M | |
| -2.19% | +6.01% | +66.90% | +123.30% | 56.21B | |
| +0.55% | +8.49% | +77.09% | +100.93% | 55.38B | |
| +0.93% | +4.11% | -12.64% | -12.98% | 23.75B | |
| +0.36% | +3.42% | +9.61% | +407.11% | 23.19B | |
| +3.12% | +7.85% | +39.18% | -6.30% | 18.14B | |
| +0.28% | +5.51% | +36.93% | -30.23% | 16.84B | |
| +1.49% | +17.24% | +174.91% | +344.55% | 15.86B | |
| -0.83% | +2.06% | +23.70% | +182.37% | 13.56B | |
| +6.79% | +12.65% | +41.28% | - | 12.97B | |
| Average | +1.15% | +7.22% | +50.38% | +117.62% | 23.62B | |
| Weighted average by Cap. | +0.41% | +6.61% | +54.74% | +129.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 16M 14.05M 12.93M 12.05M 22.72M 1.52B 23.19M 156M 60.26M 747M 60.08M 58.78M 2.6B |
| Net income | -77.34M -67.91M -62.5M -58.24M -110M -7.35B -112M -752M -291M -3.61B -290M -284M -12.56B | -93.9M -82.45M -75.89M -70.72M -133M -8.93B -136M -913M -354M -4.38B -353M -345M -15.25B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-01 | US$5.050 | +1.20% | 1,102,004 |
| 26-06-30 | US$4.990 | -1.19% | 1,284,362 |
| 26-06-29 | US$5.050 | +6.09% | 1,938,815 |
| 26-06-26 | US$4.760 | +5.08% | 8,407,499 |
| 26-06-25 | US$4.530 | -1.52% | 970,570 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMRX Stock
Select your edition
All financial news and data tailored to specific country editions
